SUMMARY In the present study, the dynamics of the cerebral blood flow (CBF) and ventilatory response to hypercapnia was investigated in a group of patients with cerebrovascular disease and compared to responses measured in a group of normal volunteers. There was a significant correlation between the rapidity of the transient CBF and ventilatory responses and the severity of the cerebrovascular disease. While the steady state CBF response showed no such correlation, the steady state ventilatory response was reduced in patients with severe cerebrovascular disease. Various explanations for the differences in the dynamic responses of CBF and ventilation in patients with mild or severe cerebrovascular disease compared to normal subjects are considered. Measurement of these circulatory and ventilatory responses may be sensitive means for assessing the changing status of patients with cerebrovascular disease.
THE CLOSELY COORDINATED ADJUSTMENTS in ventilation and cerebral blood flow (CBF) which guard the acid-base balance of the brain may be upset in cerebrovascular disease. Cerebrovascular disease may significantly affect the usual increase in CBF that occurs with hypercapnia. 1 ' 6 It may also alter the steady state ventilatory response to CO 2 either by interfering specifically with the function of respiratory neurons or by causing generalized ischemia, thus interfering with brain metabolism. Besides disturbing steady state responses, it seems reasonable to expect that cerebrovascular disease can produce more subtle functional changes, interfering with the rapidity of CBF and ventilatory responses to the addition and removal of CO 2 from the inspired air, sometimes even before obvious changes in the magnitude of the steady state response can be observed. 11 In the present study, the dynamics of the CBF and ventilatory response to hypercapnia was investigated in a group of patients with cerebrovascular disease and compared to responses measured in a group of normal volunteers.
Methods
The ventilatory and CBF response to 5% CO 2 inhalation and its removal were determined in four normal subjects and 18 patients with mild to severe cerebrovascular disease as determined by clinical and angiographical findings. The patients had had their neurological deficit for at least five days prior to study.
In the normal subjects, a catheter was placed in the brachial artery and internal jugular vein under local anesthesia. The venous catheter was advanced into the jugular bulb with fluoroscopic guidance. A steady state CBF measurement was then performed by the Kety-Schmidt technique using Kr 85 after waiting 30 minutes for the subject to stabilize. 12 The blood samples containing Kr 85 were measured in a liquid scintillation counter. 19 During the measurement of control CBF, the subject breathed 30% O 2 through a one-way valve. Ventilation was determined in this steady state period by measuring expired gas collected for three minutes with a dry gas meter. The inspired gas was then abruptly switched to 5% CO 2 -30% O 2 in N 2 , and arterial and cerebral venous samples were obtained intermittently for pH, Pco 2 and O 2 content. A blood gas analyzer with appropriate electrodes (Radiometer PHM-71, Copenhagen, Denmark) and an oximeter (Cooximeter Model 182, Instrumentation Laboratories, Springfield, Massachusetts) were used for these determinations. The ventilation of the subject was continuously monitored by electronically integrating the airflow signal obtained from a pneumotachygraph connected to the expired gas port of the breathing valve. End-tidal Pco 2 was continuously monitored with an infrared CO 2 analyzer (Beckman LB-1, Palo Alto, California). Continuous measurements were also made of blood pressure and EKG. The on-transient response was followed for 20 minutes and then a second steady state determination of ventilation and CBF was made with Kr 86 while the subject continued to breathe 5% CO 2 . The inhaled gas was then abruptly switched back to 30% O 2 in N 2 and the off-transient monitored as before for 20 minutes. Finally, a third steady state determination of ventilation was made and CBF determined with Kr 85 . In the patients, total and regional cerebral blood flows were measured in the steady state by the 1S3 Xe arterial injection technique during and either before or after 5% CO 2 inhalations as previously described." In ten patients, the ventilation and CBF were measured as above during the ontransient, and in eight other patients, during the off-transient.
In both patients and normal subjects, the reciprocal of the arterial-cerebral venous difference in O 2 content was used as a measure of CBF during the transient studies. This is only a valid measure of changes in CBF if the cerebral metabolic rate for oxygen (CMROj) does not change significantly with changes in CO 2 . In normal subjects, this has been shown to be true under conditions similar to those of the present study. 2 In the 18 patients studied, no statistically significant change in CMRO 2 during hypercapnia was observed: mean CMRO 2 was 2.23 ml/100 gm per minute during hypercapnia and 2.35 ml/100 gm per minute in the absence of hypercapnia. Table 2 shows that the CMRO 2 is significantly reduced in the patients with severe disease (p < 0.001) compared to either the patients with mild disease or the normal subjects. The ventilatory response to CO 2 was significantly less in the patients with more severe clinical cerebrovascular disease than it was in either the patients with milder illness or the control subjects. Also, the steady state CBF response was nearly identical in the two patient groups. Correlation between CMRO 2 and the steady state CBF or ventilatory response to CO 2 was likewise poor (r = 0.32 and 0.25 respectively).
RESPONSES OF CBF AND VENTILATION TO
Examples of the time course of the increases in arterial and cerebral venous Pco 2 , CBF and ventilation with 5% CO 2 inhalation are illustrated in figure 1 in patients from the two clinical groups and in normal subjects.
In the normal subjects the time course of the increase in CBF was similar to that of arterial Pco 2 , but an overshoot occurred in the CBF response in the patients with mild cerebrovascular disease that was not present in the arterial Pco 2 . The rise in ventilation in both these groups was much slower than that of CBF, and the rate of increase of cerebral venous Pco 2 is slower yet.
In contrast, in the patients with severe cerebrovascular disease, the rate of change of CBF was much slower than that of arterial Pco 2 , while ventilation and arterial Pco 2 rose at about the same rate and there were no overshoots.
In order to more easily compare the transient ventilatory and cerebral blood flow response in the two groups of patients with the normal response, the response to a step change in arterial Pco 2 was calculated by standard techniques. 20 In this way, any difference in the CBF or ventilatory response caused by difference in the arterial Pco 2 input function was eliminated.
The average change in CBF for a step change in Paco 2 is illustrated in figure 2 . The CBF response was faster in the mild than in the severe cases. Three of the four normal subjects also showed a slight overshoot (8% on the average) in the CBF response. The 90% response time of the CBF for the mild cases (Group 1) was 0.4 ± 0.1 minute, and for the severe cases (Group 2), 3.9 ± 0.8 minute. This difference is significant at the p < 0.005 level. There was also a significant direct correlation between the 90% response time of the CBF in the patients and their CMRO 2 (r = 0.68 and p < 0.025). Figure 3 shows the average on-ventilatory response as calculated for a step increase in Pco 2 . No overshoot was present in the ventilatory response of normals or patients with mild cerebrovascular disease, but was present in patients with severe disease. The 90% response time is significantly less (p < 0.01) in patients with severe disease (1.8 ± 0.5 minutes) than in patients with mild cerebrovascular disease (5.3 ± 0.76 minutes). There is a significant inverse correlation between the 90% response time of the ventilatory response and the CMRO 2 (r = 0.76 and p < 0.025). Figure 4 shows the average time course of the changes in arterial and jugular venous Pco 2 , in CBF and in ventilation in the normal volunteers, and in the patients from each of the two clinical groups when 5% CO 2 in the inspired gas was suddenly removed. Again, CBF changed more rapidly than NORMAL SUBJECTS ventilation in the normal volunteers and in the patients with mild cerebrovascular disease; the CBF changes were only slightly slower than the decrease in Paco 2 . In contrast, ventilation falls more rapidly than CBF in the patients with severe cerebrovascular disease. Because the arterial CO 2 input functions differed in the two patient groups, responses to a step reduction in Paco 2 were also calculated. Average changes in CBF for a step decrease in Paco 2 are compared for the two clinical groups and the normal subjects in figure 5 , while average ventilation changes are compared in figure 6 . Patients with mild cerebrovascular disease showed an undershoot in their CBF response which averaged 29%. A smaller undershoot was observed in normal volunteers, but none at all was noted in patients with severe diesase. There is a good correlation between CMRO 2 and 90% response time of CBF (r = 0.752, p < 0.05). As shown in figure 6 , the rate of change of ventilatory responses was greater in the patients with more severe disease than in either normal patients or patients with mild cerebrovascular disease, but the correlation between 90% response time of ventilation and CMRO 2 is not significant.
Discussion
In the present study, the steady state level and the rapidity of the ventilatory and CBF response to the addition and removal of 5% CO 2 from the inspired air were measured in 18 patients with cerebrovascular disease; the results were compared to similar data obtained in four normal volunteers. Steady state CBF responses to CO 2 were only slightly decreased in the patients with cerebrovascular disease; there was no relation between the blunting of the response and the clinical severity of the disease. In contrast, there was a significant correlation in the patients between the rapidity of the CBF responses and the severity of vascular abnormalities in the brain as indicated by the cerebral oxygen consumption. The worse the disease, the more sluggish was the change in CBF. Steady state ventilatory responses were at the lower limit of normal in the group with severe vascular disease of the brain. However, the rapidity of ventilatory response was greater in these patients and correlated directly with the CMRO 2 .
Blunting of the steady state CBF response to hypercapnia and hypocapnia has been reported in some but not in all studies of patients with vascular disease of the brain. 3 ' 21 The effect of cerebrovascular disease seems to be uneven and in patients with acute strokes, both ischemic and hyperemic foci have been described. 22 " 24 In some areas, vascular responses to changes in blood gas tensions appear to be preserved; in others, only the response to hypocapnia persists; and in still others, paradoxical changes have been observed so that CBF decreases as Pco 2 is increased. 22 Both the fact that the usual methods of assessing CBF measure only the average flow per volume of cerebral tissue and the fact that relatively great variability is seen even in the responses of normal individuals interfere with the clinical usefulness of the steady state CO 2 response. Only a few studies have tried to evaluate the dynamics of the CBF response to blood gas changes 11 ' 25 and none have attempted to correct the transient response for differences in the time course of the input function, the Paco 2 change. The results of the present study suggest that the time course of CBF changes to step changes in Paco 2 may be clinically useful since abnormalities in this response are detectable even before abnormal steady state responses are present.
The differences in the speed of the transient CBF response in patients with mild or severe cerebrovascular disease can be explained in several ways, because it is uncertain whether changes in arterial, extracellular or intracellular Pco 2 (or pH) are responsible for the brain blood flow changes that oc- Blood flow seems to be highest in those areas of the brain with the greatest metabolic rate, and in the normal brain, the ratio of blood flow to metabolism is nearly the same throughout the brain. 30 If CBF is controlled by a single factor such as extracellular fluid (ECF) pH, the increase in the rapidity of the transient CBF response seen in patients with mild cerebrovascular disease could be explained by increas- Regions of the brain in which the ratio of flow to metabolic rate is high would equilibrate more rapidly with CO 2 because of their higher flow and would have a higher venous O 2 content than would regions where the ratio of flow to metabolism is low. Consequently, these high blood flow regions would contribute disproportionately more to the mixed cerebral venous blood. 81 Because the blood from regions with a higher ratio of perfusion to metabolic rates would have a greater O 2 content than would blood from regions with a low ratio, the mixed arteriovenous (AV) difference in O 2 content would narrow more rapidly than it would if flow, metabolic and hence C 0 2 equilibration rates were more uniform. Apparent overshoots in the CBF response would occur if there were areas in which CBF responded paradoxically to CO 2 changes -blood flow decreasing rather than increasing with hypercapnia. Initially the high flow regions would contribute more to the AV-O 2 difference and tend to narrow it, while later when the flow areas were represented more in proportion to their true weight the mean AV-O 2 difference would widen. As increasingly severe disease interfered more extensively with gas exchange across capillaries, changes in ECF Pco 2 and pH would be uniformly slowed throughout the brain, reducing the speed of the CBF response. Also, with extensive vascular lesions, the ability of the smooth muscle in the blood vessel wall to shorten might be affected, further diminishing the rate with which vascular dilation and contraction occurred with C0 2 .
Recent studies by Greenberg et al. 32 suggest that CBF responses to CO 2 have a rapid component and a slower component. The slow component may depend on changes in ECF pH or brain Pco 2 , while the rapid component may depend on changes in Paco 2 . Alternatively, other studies have suggested that the cerebrovascular response to C 0 2 may involve a neural component which is presumably rapid. Both these ideas would be compatible with the observations made in the present study which show that CBF in normal subjects responds more rapidly than changes in cerebral venous Pco 2 but more slowly than changes in arterial Pco 2 .
• SEVERE O NORMAL 4 6 TIME (MINUTES) FIGURE 6. Average change in ventilation with time to a step decrease in PaCCh in normal subjects, patients with mild cerebrovascular disease and patients with severe cerebrovascular disease.
If the rapidity and the degree of the CBF response to CO 2 depend on changes at two sites, the differences in the transient CBF response in patients with mild or severe cerebrovascular disease could be explained as follows: In mild disease, a decrease in the sensitivity of the vascular response to the slow component would tend to accelerate the transient CBF response; however, with more severe disease, as shortening of the vascular smooth muscle was mechanically slowed, the rate of the transient response would decrease.
In the present study, the steady state ventilatory response to CO 2 was reduced in subjects with the most severe cerebrovascular disease. However, the ventilatory response to C0 2 is variably affected in stroke patients depending on the location of the cerebrovascular lesions. Heightened steady state ventilatory responses to C0 2 have been observed in vascular disease affecting the cortex, while a depressed response has been noted in patients with medullary lesions. 8637 Abnormalities in the transient as well as the steady state ventilatory responses to CO 2 were observed in the present study. The significant inverse relationship between the rapidity of the ventilatory response to C 0 2 inhalation and the clinical severity of the vascular disease suggests that measurements of these ventilatory responses may be a useful noninvasive way for assessing the changing status of these patients.
While CBF dynamics were depressed with severe cerebrovascular disease, ventilatory dynamics seemed to be accelerated. Although 70% to 90% of the ventilatory response to CO 2 is determined by the pH of brain ECF, 10% to 30% of the ventilatory response to CO 2 in normal individuals arises in the peripheral chemoreceptors which respond rapidly to hypercapnia. 38 Cerebrovascular disease would be expected to depress respiratory neuron function in the brain, reduce the sensitivity to the centrally mediated response to CO 2 , and consequently produce a blunting of total CO 2 response as was observed in the patients with severe stroke. This reduction in the role of central CO 2 receptors would increase the relative contribution of the peripheral arterial chemoreceptors to CO 2 response which in turn would accelerate the rate of ventilatory response to CO 2 as observed in this study. Although this hypothesis requires further experimental con-STROKE VOL. 7, No. 6, NOVEMBER-DECEMBER 1976 firmation, an increase in peripheral chemoreceptor contribution to CO 2 response could also decrease the stability of ventilatory control. 39 The decrease in stability could contribute to production of the periodic breathing sometimes observed in patients with severe cerebrovascular disease. Additional experimental study is needed to evaluate the stability of ventilatory control in these patients.
